Dartmouth-Hitchcock logo
Medicine Grand Rounds - Severe Acute Respiratory Syndrome Coronavirus 2 COVID-19: Science Update, March 20, 2020

Dr. Talbot reviews the timeline of the COVID-19 virus from its initial outbreak in China through March 20, 2020, including the transmissibility percentages and likely incubation period. She explains that the virus is spread primarily through droplets, can survive for several hours and possibly days on fomite or inanimate objects, but can be eliminated with effective household cleaning solutions. She discusses presenting symptoms as well as blood chemistry and imaging changes, and the severity risk for certain age groups and those with pre-existing conditions. She discusses combination drug treatments that are being studied in patients for potential effective mitigation. She reviews strategies for testing and control, and the challenges that will define the local and global scope of the pandemic.

Activity Details

Start Date:  March 20, 2020
End Date:  March 20, 2023

You may claim CME credit for successful completion of this online course. In order to claim credit, you must follow these steps:

  1. Register for the learning activity by creating an account or logging in to your account.
  2. Click Continue to navigate to the Activity Material tab. Click View Presentation to view the recording. View the entire presentation.
  3. Return to this Activity page.
  4. Click Continue to navigate to the Evaluation tab; then click the Launch button to start the evaluation.
  5. Complete and Submit the evaluation and attestation form.

When the evaluation is submitted, you will be awarded credit. You may access your transcript for verification of participation at any time via Your Account. Need help? Visit the Support Page, send an Email, or call the Center for Learning and Professional Development at (603) 653-1234, Option 1.

Learning Outcome

Participants will be able to review the principle clinical features which define scleroderma, discuss the impact of new therapies on the current management of scleroderma and outline the future pipeline of scleroderma therapies.

  • Elizabeth A. Talbot, MD
    Professor of Medicine
    Geisel School of Medicine at Dartmouth
    Section of Infectious Disease & International Health, Dartmouth-Hitchcock Medical Center
    Deputy State Epidemiologist, New Hampshire Department of Health and Human Services

    About our presenter:
    Dr. Talbot has had extensive experience in international and domestic infectious disease control through outbreak investigations, clinical projects, research, and consultation. She trained at Duke University and with the CDC's Epidemic Intelligence Service, then was stationed in Botswana and was seconded to the World Health Organization for SARS-CoV-1 response before coming to Dartmouth.
  • Antonia L. Altomare, DO, MPH
    Assistant Professor of Medicine
    Geisel School of Medicine at Dartmouth
    Section of Infectious Disease & International Health
    Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center
    Program Director for the Ryan White Part D HIV Program

    About our presenter:  
    Dr. Altomare completed her medical education at the New York College of Osteopathic Medicine and residencies in Internal Medicine and Preventive Medicine, as well as a fellowship in Infectious Diseases at DHMC.  She has a Masters of Public Health from the Dartmouth Institute for Health Policy & Clinical Practice. Her primary interests are quality improvement within infection control and HIV care, and she treats general infectious diseases and infections in immunocompromised hosts, with an interest in HIV.

Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Dartmouth-Hitchcock designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Successful Completion

In order to receive credit for this Continuing Medical Education (CME) activity, you must:

  • View the entire presentation
  • Complete the online Attestation of Attendance & Evaluation Form (you must register to access).

In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.

The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for Severe Acute Respiratory Syndrome Coronavirus 2 COVID-19: Science Update, March 20, 2020 (Medicine Grand Rounds) have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.

* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio. 

* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion. 

Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.

*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.

Provider Contact Information

Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
Dartmouth-Hitchcock Medical Center

Type:     Internet Activity (Enduring Material)
14 Registered Users